Two German companies, Mahle GmbH and Schott Pharma AG, are exploring initial public offerings of their Indian businesses that could raise as much as $400 million each, according to people familiar with the matter, as multinational firms seek to tap the premium valuations commanded by their locally listed peers.
Nous affichons publiquement l'idee principale. Creez un compte gratuit pour lire l'article complet, l'enregistrer, le commenter et le relier au contexte marches et OSINT.